文献速递生殖医学

全胚冷冻IVF周期中获卵数与新生儿结局的关联

Association between the number of oocytes retrieved and neonatal outcomes after freeze-all IVF cycles.
PubMed 文献 · Hum Reprod · 2019-01-01

这项回顾性队列研究纳入2006年11月至2017年12月在中国经全胚冷冻策略实现单胎分娩的14170名女性,按获卵数分为1-3、4-9、10-15、16-20及>20五组,以10-15组为参照。调整混杂因素后,获卵数≥16组与10-15组相比不良新生儿结局风险未增加,不同获卵数组间早产、低出生体重等风险无显著差异。

要点

  • 全胚冷冻周期中,获卵数≥16与10-15枚相比不良新生儿结局风险未增加。
  • 不同获卵数组间早产、低出生体重、先天畸形等风险无显著差异。
  • 卵巢低反应(1-3枚)组早期早产粗OR为2.001,调整后未达统计学显著。

核心结论

  • 全胚冷冻周期中,获卵数与不良新生儿结局无关联,这对计划采用全胚冷冻策略的临床医生和患者是令人安心的发现。

研究设计与样本

  • 回顾性队列研究,纳入2006年11月至2017年12月在中国经全胚冷冻策略实现单胎分娩的14170名女性,仅纳入一次卵巢刺激后的首次分娩。

主要发现

  • 调整混杂因素后,不同获卵数组间早产(P=0.837)、低出生体重(P=0.974)、早期早产(P=0.341)、极低出生体重(P=0.848)、先天畸形(P=0.916)及其他不良新生儿结局风险无显著差异。
  • 卵巢低反应(1-3枚)组与正常反应(10-15枚)组相比早期早产风险更高(1.5% vs 0.8%),粗OR为2.001(95%CI 1.159-3.465,P=0.013)。
  • 调整混杂因素后,卵巢低反应(1-3枚)组与正常反应(10-15枚)组早期早产差异未达统计学显著(调整OR 1.753,95%CI 0.997-3.081,P=0.051)。

局限性

  • 缺乏吸烟、妊娠期糖尿病及子痫前期病史等已知混杂因素数据。
  • 作为回顾性研究,未知混杂因素可能影响结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is there any association between the number of oocytes retrieved and neonatal outcomes following IVF/ICSI treatment for patients using a freeze-all strategy? SUMMARY ANSWER: There was no increased risk of adverse neonatal outcomes in cycles with high number of oocytes retrieved (≥ 16) compared to those with 10-15 oocytes retrieved in freeze-all cycles. WHAT IS KNOWN ALREADY: Recent studies have found that there is an increased risk of preterm birth (PTB, <37 weeks gestation) and low birth weight (LBW, <2500 g) following IVF in women with a high number (>20) of oocytes retrieved in fresh embryo transfer (ET) cycles. Other studies have found that there is an association between the number of oocytes retrieved and placenta praevia. However, the association between the number of oocytes retrieved and neonatal outcomes when using a freeze-all strategy is unknown. STUDY DESIGN, SIZE, DURATION: This retrospective cohort study included 14 170 women with singleton deliveries achieved by a freeze-all strategy performed between November 2006 and December 2017 in China. Only the first delivery from one episode of ovarian stimulation was included. PARTICIPANTS/MATERIALS, SETTING, METHODS: Only cycles using a freeze-all strategy performed during the study period and resulting in singleton live births were included. Patients were categorized into five groups according to the number of oocytes retrieved: 1-3, 4-9, 10-15, 16-20 or >20 oocytes. In univariate and multivariate logistic regression analysis of the association between ovarian response and the outcomes of PTB, early PTB, LBW and other neonatal outcomes, the 10 to 15 oocyte category was used as a reference and other four groups were analysed as dummy variables. Multiple linear regression analysis was used to evaluate possible associations of birth weight z-scores and the number of oocytes retrieved (analysed as a continuous variable) with other confounding factors. MAIN RESULTS AND THE ROLE OF CHANCE: After adjusted for confounding factors, no significant differences were observed in the risk of PTB (P = 0.837), LBW (P = 0.974), early PTB (P = 0.341), very LBW (P = 0.848), congenital malformation (P = 0.916) and other adverse neonatal outcome among patients with different number of oocytes retrieved. There was a higher risk of early PTB among women with a poor ovarian response (1-3 oocytes) compared with women with a normal response (10-15 oocytes) (1.5% vs 0.8%), crude odds ratio (OR): 2.001, 95% CI: 1.159-3.465, P = 0.013. However, the difference was not significant after adjusting for confounders, adjusted OR: 1.753, 95% CI: 0.997-3.081, P = 0.051. LIMITATIONS, REASONS FOR CAUTION: Data on some known confounders such as smoking and medical history of gestational diabetes mellitus and preeclampsia were lacking. As with any retrospective study, unknown confounders may affect outcomes. WIDER IMPLICATIONS OF THE FINDINGS: In the freeze-all cycles, there was no association between number of oocytes retrieved and adverse neonatal outcomes. This is a reassuring finding for both clinicians and patients who are planning to use freeze-all cycles for a variety of indications. STUDY FUNDING/COMPETING INTEREST(S): Grants from the National Natural Science Foundation of China (NSFC) (31770989 to Y.W.) and the Shanghai Ninth People's Hospital Foundation of China (JYLJ030 to Y.W.). None of the authors have any conflicts of interest to declare.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Yang X, Zhang J, Wu J, et al. Association between the number of oocytes retrieved and neonatal outcomes after freeze-all IVF cycles. Hum Reprod. 2019. PMID: 31621863. doi:10.1093/humrep/dez137

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。